Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Hemorrhage | Phase 4 | ClinicalTrials |
| Blood Coagulation Disorders; Hemorrhage; Hemostatic Disorders; Intracranial Hemorrhages | Phase 4 | ClinicalTrials |
| Osteoarthritis; Osteoarthritis, Knee | Phase 2 | ClinicalTrials |
| Hemorrhage; Shock, Hemorrhagic | Phase 2/Phase 3 | ClinicalTrials |
| Shock; Shock, Septic | Phase 2 | ClinicalTrials |
| Hemorrhage; Intracranial Hemorrhages | Phase 1 | ClinicalTrials |
| Supranuclear Palsy, Progressive | Phase 1 | ClinicalTrials |
| Blood Coagulation Disorders; Hemostatic Disorders | Phase 3 | ClinicalTrials |
| Fasciitis; Fasciitis, Plantar | Phase 4 | ClinicalTrials |
| Blood Coagulation Disorders; Hemorrhage; Hemostatic Disorders | Phase 3 | ClinicalTrials |
| Blood Coagulation Disorders; Hemostatic Disorders | Phase 4 | ClinicalTrials |
| Liver Diseases | Phase 4 | ClinicalTrials |
| Aneurysm; Aortic Aneurysm, Abdominal; Blood Coagulation Disorders; Hemostatic Disorders | Phase 4 | ClinicalTrials |
| Aneurysm; Aortic Aneurysm; Aortic Aneurysm, Thoracic | Phase 4 | ClinicalTrials |
| Hemorrhage | Phase 2 | ClinicalTrials |
CONTENTS